2019. Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S2. DOI:https://doi.org/10.25251/skin.3.supp.2.